Newsmeme!
Discover News you didn't know existed
Dyspareunia
News
Related Video News
No related video news stories found.
Related Videos
No related videos found.
Alternative Therapy for Adhesion and Endometriosis Pain Examined in New Book 'Miracle Moms, Better Sex, Less Pain'
Published November 18, 2008, 11:01 pm, PRWeb via Yahoo! News
In an upcoming book, 'Miracle Moms, Better Sex, Less Pain,' researchers examine a non-surgical therapy to treat adhesion and endometriosis pain.
Low Complication Profile For Pelvic Floor Repair - New Restorelle™ Series Demonstrates Near Zero Mesh Erosion Rate
Published November 18, 2008, 12:10 pm, Medical News Today
Mpathy Medical, a rapidly growing medical device company which specializes in restoring pelvic health to women, today announced the findings of a retrospective cohort study carried out by Red Alinsod, MD, FACOG, FACS, ACGE, Laguna Beach, CA.
Smartmesh Technology Offers Low Complication Profile for Pelvic Floor Repair
Published November 17, 2008, 9:58 am, Business Wire via Yahoo! Finance
RAYNHAM, Mass.----Mpathy Medical, a rapidly growing medical device company which has developed and brought to market a range of surgical solutions used to restore pelvic health to women, today announced the findings of a retrospective cohort study carried out by Red Alinsod, MD, FACOG, FACS, ACGE, Laguna Beach, CA.
FDA Approves Low-dose Regimen Of Premarin Vaginal Cream To Treat Moderate To Severe Postmenopausal Dyspareunia Painful ...
Published November 15, 2008, 4:09 am, Medical News Today
PREMARIN® (conjugated estrogens) Vaginal Cream 0.5 g has been approved by the U.S. Food and Drug Administration (FDA) for a new indication and a new less frequent twice-weekly dosing regimen to treat moderate to severe postmenopausal dyspareunia (painful sexual intercourse) announced Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE).
US FDA approves Premarin cream for postmenopausal dyspareunia
Published November 15, 2008, 1:49 am, PharmaBiz
Premarin (conjugated estrogens) Vaginal cream 0.5 g has been approved by the US Food and Drug Administration (FDA) for a new indication and a new less frequent twice-weekly dosing regimen to treat moderate to severe postmenopausal dyspareunia (painful sexual intercourse) announced Wyeth Pharmaceuticals, a division of Wyeth.
Wyeth wins FDA approval for new indication of Premarin vaginal cream
Published November 14, 2008, 6:45 pm, Pharmaceutical Business Review
Wyeth Pharmaceuticals, a division of Wyeth, has announced that Premarin vaginal cream 0.5gm has been approved by the FDA for a new indication and a new less frequent twice-weekly dosing regimen to treat moderate to severe postmenopausal dyspareunia.
Related News Resources:
> HGH News
News Directory
Get started fast by using a pre-defined news directory category
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |